Vienna, Austria

Bernhard Kueenburg

This inventor holds 1 USPTO granted patent. Top assignee: Onepharm Research & Development Gmbh. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernhard Kueenburg. Retrieved from https://idiyas.com/inventor/bernhard-kueenburg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernhard Kueenburg: Innovator in Medicinal Chemistry

Introduction

Bernhard Kueenburg is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative research and development efforts.

Latest Patents

Kueenburg holds a patent for N-hydroxy C29-amide derivatives of oleandrane. This invention encompasses novel triterpene compounds of general formula I, wherein R, R, R, R, R, and R are defined as in the claim. These compounds are suitable for the prevention and/or treatment of diseases mediated by 11 β-HSD, and they can be used for preparing a medicament with the aforementioned properties. He has 1 patent to his name.

Career Highlights

Kueenburg is associated with Onepharm Research & Development GmbH, where he continues to push the boundaries of pharmaceutical innovation. His work focuses on developing new therapeutic agents that can address various health challenges.

Collaborations

Throughout his career, Kueenburg has collaborated with esteemed colleagues, including Laszlo Czollner and Paul Kosma. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Bernhard Kueenburg's contributions to medicinal chemistry and his innovative patent work exemplify his commitment to advancing healthcare solutions. His ongoing efforts at Onepharm Research & Development GmbH continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…